Where does Medica Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medica Corporation ranks #21,434 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medica Corporation hold?

Medica Corporation holds 13 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Medica Corporation's Innovation Score?

Medica Corporation has an Innovation Score of 46.8 out of 100 (top 20% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medica Corporation focus on?

Medica Corporation's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 12 patents, ranking #1,245 of 7,863 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Medica Corporation's patent grant rate increasing or decreasing?

Medica Corporation's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Medica Corporation's patents?

Medica Corporation's patents average 25.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medica Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Medica Corporation

USPTO PatentsView assignee record - 13 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medica ranks #21,434 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 7 technology areas.

#21,434
of 49,997 US assignees by volume: Top 20%
by Innovation Score (46.8/100): 25.2
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21434 · US Corporation #21,434 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,434/49,997
PHOTO-FINISH McAlpine &
CPC-NARROW G01N · 7 areas
INNOV-PAR 46.8/100
CLAIMS-DENSE 25.2 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: McAlpine & Co. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medica’s 46.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (19%) Velocity 13.3 pts (28%) Breadth 9.4 pts (20%) Claim depth 15.0 pts (32%)

Qualcomm Incorporated · highest

85
Medica · this assignee

47
3D Lighting… · lowest

7

What this shows Medica's Innovation Score is 46.8/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medica?

Each dot is one of Medica’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medica’s own 25.2 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medica vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medica's grants concentrate

Medica Corporation is a focused PatentsView assignee: 7 CPC subclasses with 92.3% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2015. By volume, Medica sits between McAlpine & Co. Ltd. and Metabolix, Inc..

Medica's three-year grant acceleration

Medica Corporation shows 6 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mcalpine &

13
Measurement Speci…

13
Med-eng

13
Medsource Interna…

13
Meharry Medical C…

13
Mercury Kingdom A…

13
Mesaplexx Pty

13
Metabolix

13
Medica ◀

13

What this shows Medica holds 13 patents at rank #21,457, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medica

By rank, the assignees closest to #21,457 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Medica's primary technology class.

Medica's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Medica Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	7.7%
2016	1	7.7%
2017	1	7.7%
2019	1	7.7%
2020	1	7.7%
2021	1	7.7%
2022	2	15.4%
2023	1	7.7%
2024	3	23.1%
2025partial year	1	7.7%

Which technologies does Medica Corporation patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 12

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 8

G06V - Image OR Video Recognition OR Understanding 5

Y10T - Technical Subjects Covered BY Former US Classification 4

G02B - Optical Elements, Systems OR Apparatus 2

G06F - Electric Digital Data Processing 2

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 2

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medica Corporation's patent record in context - here's where to go next.

Medica Corporation's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 92.3% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #21,434 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medica Corporation against McAlpine & Co. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.